Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2022 16:01 ET | Source: Axogen, Inc.

Axogen, Inc Reports 2022 Second Quarter Financial Results

ALACHUA, Fla. and TAMPA, Fla., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
July 29, 2022 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to present at Canaccord Genuity's 42nd Annual Growth Conference

ALACHUA. Fla. and TAMPA, Fla, July 29, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
July 18, 2022 16:00 ET | Source: Axogen, Inc.

Axogen, Inc. Announces Organizational Updates, Preliminary Second Quarter Revenue and Reaffirms Full-Year 2022 Financial Guidance

Organizational updates are part of plan to bring additional focus on leveraging clinical data to accelerate market development and the pace of innovation Preliminary unaudited second quarter...
July 11, 2022 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. Appoints William Burke to Board of Directors

ALACHUA, Fla. and TAMPA, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
May 18, 2022 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference

ALACHUA, Fla. and TAMPA, Fla., May 18, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
May 04, 2022 16:05 ET | Source: Axogen, Inc.

Axogen, Inc Reports 2022 First Quarter Financial Results

ALACHUA, Fla. and TAMPA, Fla., May 04, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
May 04, 2022 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft

ALACHUA, Fla. and TAMPA, Fla., May 04, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
April 13, 2022 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report First Quarter 2022 Financial Results and Host Conference Call on May 4, 2022

ALACHUA, Fla. and TAMPA, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
March 17, 2022 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. publishes inaugural ESG Report

ALACHUA, Fla. and TAMPA, Fla., March 17, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
February 22, 2022 16:34 ET | Source: Axogen, Inc.

Axogen, Inc. Reports 2021 Fourth Quarter and Full-Year Financial Results

ALACHUA, Fla. and TAMPA, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...